DRUG · Unmapped registry intervention
PRX-03140
Find medicine records ·
Find other trials using this name
Clinical trial
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
NCT00693004
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Donepezil
Normalized identity: donepezilView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Epix Pharmaceuticals, Inc.lead sponsor
Mapped research locations
TampaFlorida, United States2PhoenixArizona, United States2New YorkNew York, United States1HoustonTexas, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1CharlotteNorth Carolina, United States1TucsonArizona, United States1BrooklynNew York, United States1TorranceCalifornia, United States1NorfolkVirginia, United States1TulsaOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00693004 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.